Press Release

Envision enriches its creative touch!

Envision Pharma Group acquires Touch Creative Design Limited

To underpin its commitment to clients to provide pioneering scientific multichannel medical communication solutions alongside its purpose built industry-leading software, Envision is delighted to announce the acquisition of Touch Creative Design Agency.

The Touch team brings a wealth of experience, creativity, and an impressive portfolio of innovative projects within the healthcare arena. Touch will collaborate with Envision to deliver significant creative and digital capabilities to extend Envision’s ever-expanding multichannel offering. Bringing the organisations together will also give the agency extended reach and investment to support new initiatives.

Envision’s Chief Strategy Officer, David Thompson, commented, “We are thrilled to welcome Touch to the Envision family. The addition of Touch to the group augments our existing capabilities and further cements our core principle of marrying scientific expertise and technology. Touch’s cutting-edge ideas, skills, and experience enhances our multichannel offering and ensures clients continue to receive best-in-class Medical Affairs solutions.”

Touch Managing Director, Vonig Watson, stated, “For 13 years Touch has established itself as a talented pharma/healthcare creative communications agency, with innovation, reliability, and creativity at its core. It is with great pleasure that Touch has now become part of Envision, enabling our combined multichannel communications expertise to be extended to a wider audience and, ultimately, to benefit more patients worldwide. Together we aim to raise the bar in delivering full-service pharma/healthcare multichannel communications for our clients.”


About Envision

Founded in 2001, Envision Pharma is an international, innovative global technology and scientific communication company serving pharmaceutical, biotechnology, and medical device companies. Initially focusing on re-inventing the way biopharma companies managed their global data communications programs through the use of smart technology and best-in-class publication planning, Envision has evolved into a number of parallel business verticals, now offering a unique blend of Medical Affairs – focused, strategic multichannel data dissemination and consultancy services, enhanced with industry-leading, complementary technology solutions.

Envision now has 14 offices, five in the UK – Bishop's Stortford, Horsham, London (Hammersmith), Marlow, and Wilmslow; one in Serbia; six in the US – Philadelphia, PA; New York, NY; Southport, CT; Madison, NJ, Stirling, NJ; and Glastonbury, CT; and two in Asia Pacific – Tokyo and Sydney. The company employs more than 600 team members, including over 200 highly qualified in-house medical writers and over 100 technology solutions team members involved with platform development and customer support. 


About Touch

Founded in 2004 and located in Bishop's Stortford, UK, Touch Creative Design is a pharma/healthcare focused agency with multi-industry experience – predominantly healthcare focused they also work across other industries. This experience keeps their ideas fresh, allowing them to evaluate and experiment with the latest technologies and learn what works with respect to customer engagement. Specialities include creative strategy development, digital and technology-based experiences, exhibitions and event services, branding and traditional creative media. www.touchcreative.co.uk/epg

The acquisition was supported by Envision’s equity partners – Ardian, the independent private investment company www.ardian.com, and GHO Capital, the specialist European investor in healthcare www.ghocapital.com. Additional terms of the transaction were not disclosed.


For further information, please contact:

David Thompson
Chief Strategy Officer
Envision Pharma Group
Tel: +44 (0)7557 238911